Search fresh public links, source activity, and ready-to-use post angles for Bend Bioscience.
Fresh curated links around Bend Bioscience are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
BridgeBio Anonymous (not verified) Thu, 07/09/2026 - 09:10 field_thread_url https://cafepharma.com/boards/threads/bridgebio.698762/ boar...
This Parse Biosciences and bit.bio alliance combines single-cell RNA sequencing and causal transcriptomics to map transcription factor-driven cell identity, enabling improved disea...
The workflow pairs Bio-Techne’s MauriceFlex imaged capillary isoelectric focusing fractionation system with Refeyn's TwoMP mass photometry platform to connect charge heterogeneity...
BioVenic announced enhanced support for veterinary organoid culture system development, combining animal-free recombinant protein-informed medium optimization, 3D organoid model es...
Cytomos says its benchtop cell analytics intelligence system combines the compact Celledonia analyzer with the sensors of the AuraCyt modules to transform complex cellular data int...
Eclipse Bioinnovations uses RNA sequencing in eSENSE Breakâ„¢ to map RNA fragmentation at single-nucleotide resolution, helping developers understand RNA stability and structural v...
The biotechnology startup emerged from stealth with a peptide drug it claims to have the potential to reverse lung scarring in people with idiopathic pulmonary fibrosis.
By combining closed-loop functional screening with AI-driven design, Bonito and DaltonTx aim to accelerate discovery of delivery systems that can reach tissues and cell types that...
The company, which was built by Bain Capital, has now raised more than $426 million in its quest to advance a portfolio of Bristol Myers drugs.
Company Name: Kezar Life Sciences Industry: Biotech Use: Corporate graphics for pitch decks, website, and social media Client Lead – Mike Wolfe VP Finance and Business Operations a...
In an extraordinary leap forward for mitochondrial biology and peptide therapeutics, a research team led by Hendgen-Cotta and colleagues has unveiled a groundbreaking discovery tha...
The Blank Bio and PacBio collaboration combines long-read RNA sequencing and AI foundation models to improve biomarker discovery, patient stratification, and precision... The post...
Jill P. Mesirov, PhD, a luminary in the worlds of mathematics and computational biology, has embarked on a new chapter in her distinguished career by joining the Sanford Burnham Pr...
AI-designed microneedles bend at body temperature to close diabetic wounds while delivering DNA therapy and antibacterial protection.
Biotech Graphics: Illustrating Synthetic Cells Client: Cell Care Therapeutics Industry: Biotech CEO: Nicolas Sohl For: Pitch Decks, Corporate website, Social Media Goal and Challen...
Beigene Anonymous (not verified) Mon, 05/25/2026 - 11:38 field_thread_url https://cafepharma.com/boards/threads/beigene.637588/ board na...
Elsewhere, Otsuka’s kidney drug hit the goal of a confirmatory trial and Vertex’s CRISPR sickle cell drug secured expanded approval.
CEO Tomoyuki Hasegawa discusses the vast potential of stem cells and the company’s life sciences goals. The post Smile Please: Wisconsin Welcomes FUJIFILM Cellular Dynamics New Hea...
Adaptive Biotechnologies is planning to separate its drug discovery and diagnostics businesses, outlining its intent to evaluate “strategic and structural alternatives” for the med...
Did you know that one in 10 Americans have a rare disease and it can take five or more years, on average, for a person with a rare disease to get an accurate diagnosis? That’s more...
The focus of the company is SERP-01, an in vivo base editing program targeting AATD developed in China and licensed from YolTech Therapeutics.
ProBio is building flexible platforms for multispecific antibodies, ADCs, and other advanced therapeutic approaches. The post From Discovery to Development in Emerging Modalities a...
Eli Lilly and Astellas will be the lead bidders at an auction for Sangamo assets. Elsewhere, an investor syndicate committed $230 million to a gene editing startup and Merck KGaA s...
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.